[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global ADC Drug Substance Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

February 2024 | 88 pages | ID: G6A8DE1CDA40EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global ADC Drug Substance market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the ADC Drug Substance industry chain, the market status of Drug R&D (ADC Drug Substance Targeting Nectin-4, ADC Drug Substance Targeting Trop-2), Medical Research (ADC Drug Substance Targeting Nectin-4, ADC Drug Substance Targeting Trop-2), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of ADC Drug Substance.

Regionally, the report analyzes the ADC Drug Substance markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global ADC Drug Substance market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the ADC Drug Substance market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the ADC Drug Substance industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., ADC Drug Substance Targeting Nectin-4, ADC Drug Substance Targeting Trop-2).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the ADC Drug Substance market.

Regional Analysis: The report involves examining the ADC Drug Substance market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the ADC Drug Substance market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to ADC Drug Substance:

Company Analysis: Report covers individual ADC Drug Substance manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards ADC Drug Substance This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug R&D, Medical Research).

Technology Analysis: Report covers specific technologies relevant to ADC Drug Substance. It assesses the current state, advancements, and potential future developments in ADC Drug Substance areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the ADC Drug Substance market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

ADC Drug Substance market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • ADC Drug Substance Targeting Nectin-4
  • ADC Drug Substance Targeting Trop-2
Market segment by Application
  • Drug R&D
  • Medical Research
  • Others
Major players covered
  • TOT Biopharm International
  • Lonza Group AG
  • WuXi XDC Cayman
  • BrightGene Bio-Medical
  • Haoyuan Pharmaceutical
  • Pfizer
  • Roche
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe ADC Drug Substance product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of ADC Drug Substance, with price, sales, revenue and global market share of ADC Drug Substance from 2019 to 2024.

Chapter 3, the ADC Drug Substance competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the ADC Drug Substance breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and ADC Drug Substance market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of ADC Drug Substance.

Chapter 14 and 15, to describe ADC Drug Substance sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of ADC Drug Substance
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global ADC Drug Substance Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 ADC Drug Substance Targeting Nectin-4
  1.3.3 ADC Drug Substance Targeting Trop-2
1.4 Market Analysis by Application
  1.4.1 Overview: Global ADC Drug Substance Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Drug R&D
  1.4.3 Medical Research
  1.4.4 Others
1.5 Global ADC Drug Substance Market Size & Forecast
  1.5.1 Global ADC Drug Substance Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global ADC Drug Substance Sales Quantity (2019-2030)
  1.5.3 Global ADC Drug Substance Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 TOT Biopharm International
  2.1.1 TOT Biopharm International Details
  2.1.2 TOT Biopharm International Major Business
  2.1.3 TOT Biopharm International ADC Drug Substance Product and Services
  2.1.4 TOT Biopharm International ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 TOT Biopharm International Recent Developments/Updates
2.2 Lonza Group AG
  2.2.1 Lonza Group AG Details
  2.2.2 Lonza Group AG Major Business
  2.2.3 Lonza Group AG ADC Drug Substance Product and Services
  2.2.4 Lonza Group AG ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Lonza Group AG Recent Developments/Updates
2.3 WuXi XDC Cayman
  2.3.1 WuXi XDC Cayman Details
  2.3.2 WuXi XDC Cayman Major Business
  2.3.3 WuXi XDC Cayman ADC Drug Substance Product and Services
  2.3.4 WuXi XDC Cayman ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 WuXi XDC Cayman Recent Developments/Updates
2.4 BrightGene Bio-Medical
  2.4.1 BrightGene Bio-Medical Details
  2.4.2 BrightGene Bio-Medical Major Business
  2.4.3 BrightGene Bio-Medical ADC Drug Substance Product and Services
  2.4.4 BrightGene Bio-Medical ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 BrightGene Bio-Medical Recent Developments/Updates
2.5 Haoyuan Pharmaceutical
  2.5.1 Haoyuan Pharmaceutical Details
  2.5.2 Haoyuan Pharmaceutical Major Business
  2.5.3 Haoyuan Pharmaceutical ADC Drug Substance Product and Services
  2.5.4 Haoyuan Pharmaceutical ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Haoyuan Pharmaceutical Recent Developments/Updates
2.6 Pfizer
  2.6.1 Pfizer Details
  2.6.2 Pfizer Major Business
  2.6.3 Pfizer ADC Drug Substance Product and Services
  2.6.4 Pfizer ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Pfizer Recent Developments/Updates
2.7 Roche
  2.7.1 Roche Details
  2.7.2 Roche Major Business
  2.7.3 Roche ADC Drug Substance Product and Services
  2.7.4 Roche ADC Drug Substance Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Roche Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: ADC DRUG SUBSTANCE BY MANUFACTURER

3.1 Global ADC Drug Substance Sales Quantity by Manufacturer (2019-2024)
3.2 Global ADC Drug Substance Revenue by Manufacturer (2019-2024)
3.3 Global ADC Drug Substance Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of ADC Drug Substance by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 ADC Drug Substance Manufacturer Market Share in 2023
  3.4.2 Top 6 ADC Drug Substance Manufacturer Market Share in 2023
3.5 ADC Drug Substance Market: Overall Company Footprint Analysis
  3.5.1 ADC Drug Substance Market: Region Footprint
  3.5.2 ADC Drug Substance Market: Company Product Type Footprint
  3.5.3 ADC Drug Substance Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global ADC Drug Substance Market Size by Region
  4.1.1 Global ADC Drug Substance Sales Quantity by Region (2019-2030)
  4.1.2 Global ADC Drug Substance Consumption Value by Region (2019-2030)
  4.1.3 Global ADC Drug Substance Average Price by Region (2019-2030)
4.2 North America ADC Drug Substance Consumption Value (2019-2030)
4.3 Europe ADC Drug Substance Consumption Value (2019-2030)
4.4 Asia-Pacific ADC Drug Substance Consumption Value (2019-2030)
4.5 South America ADC Drug Substance Consumption Value (2019-2030)
4.6 Middle East and Africa ADC Drug Substance Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global ADC Drug Substance Sales Quantity by Type (2019-2030)
5.2 Global ADC Drug Substance Consumption Value by Type (2019-2030)
5.3 Global ADC Drug Substance Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global ADC Drug Substance Sales Quantity by Application (2019-2030)
6.2 Global ADC Drug Substance Consumption Value by Application (2019-2030)
6.3 Global ADC Drug Substance Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America ADC Drug Substance Sales Quantity by Type (2019-2030)
7.2 North America ADC Drug Substance Sales Quantity by Application (2019-2030)
7.3 North America ADC Drug Substance Market Size by Country
  7.3.1 North America ADC Drug Substance Sales Quantity by Country (2019-2030)
  7.3.2 North America ADC Drug Substance Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe ADC Drug Substance Sales Quantity by Type (2019-2030)
8.2 Europe ADC Drug Substance Sales Quantity by Application (2019-2030)
8.3 Europe ADC Drug Substance Market Size by Country
  8.3.1 Europe ADC Drug Substance Sales Quantity by Country (2019-2030)
  8.3.2 Europe ADC Drug Substance Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific ADC Drug Substance Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific ADC Drug Substance Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific ADC Drug Substance Market Size by Region
  9.3.1 Asia-Pacific ADC Drug Substance Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific ADC Drug Substance Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America ADC Drug Substance Sales Quantity by Type (2019-2030)
10.2 South America ADC Drug Substance Sales Quantity by Application (2019-2030)
10.3 South America ADC Drug Substance Market Size by Country
  10.3.1 South America ADC Drug Substance Sales Quantity by Country (2019-2030)
  10.3.2 South America ADC Drug Substance Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa ADC Drug Substance Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa ADC Drug Substance Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa ADC Drug Substance Market Size by Country
  11.3.1 Middle East & Africa ADC Drug Substance Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa ADC Drug Substance Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 ADC Drug Substance Market Drivers
12.2 ADC Drug Substance Market Restraints
12.3 ADC Drug Substance Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of ADC Drug Substance and Key Manufacturers
13.2 Manufacturing Costs Percentage of ADC Drug Substance
13.3 ADC Drug Substance Production Process
13.4 ADC Drug Substance Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 ADC Drug Substance Typical Distributors
14.3 ADC Drug Substance Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global ADC Drug Substance Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global ADC Drug Substance Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. TOT Biopharm International Basic Information, Manufacturing Base and Competitors
Table 4. TOT Biopharm International Major Business
Table 5. TOT Biopharm International ADC Drug Substance Product and Services
Table 6. TOT Biopharm International ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. TOT Biopharm International Recent Developments/Updates
Table 8. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 9. Lonza Group AG Major Business
Table 10. Lonza Group AG ADC Drug Substance Product and Services
Table 11. Lonza Group AG ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Lonza Group AG Recent Developments/Updates
Table 13. WuXi XDC Cayman Basic Information, Manufacturing Base and Competitors
Table 14. WuXi XDC Cayman Major Business
Table 15. WuXi XDC Cayman ADC Drug Substance Product and Services
Table 16. WuXi XDC Cayman ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. WuXi XDC Cayman Recent Developments/Updates
Table 18. BrightGene Bio-Medical Basic Information, Manufacturing Base and Competitors
Table 19. BrightGene Bio-Medical Major Business
Table 20. BrightGene Bio-Medical ADC Drug Substance Product and Services
Table 21. BrightGene Bio-Medical ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. BrightGene Bio-Medical Recent Developments/Updates
Table 23. Haoyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Haoyuan Pharmaceutical Major Business
Table 25. Haoyuan Pharmaceutical ADC Drug Substance Product and Services
Table 26. Haoyuan Pharmaceutical ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Haoyuan Pharmaceutical Recent Developments/Updates
Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Major Business
Table 30. Pfizer ADC Drug Substance Product and Services
Table 31. Pfizer ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Pfizer Recent Developments/Updates
Table 33. Roche Basic Information, Manufacturing Base and Competitors
Table 34. Roche Major Business
Table 35. Roche ADC Drug Substance Product and Services
Table 36. Roche ADC Drug Substance Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Roche Recent Developments/Updates
Table 38. Global ADC Drug Substance Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 39. Global ADC Drug Substance Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global ADC Drug Substance Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 41. Market Position of Manufacturers in ADC Drug Substance, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and ADC Drug Substance Production Site of Key Manufacturer
Table 43. ADC Drug Substance Market: Company Product Type Footprint
Table 44. ADC Drug Substance Market: Company Product Application Footprint
Table 45. ADC Drug Substance New Market Entrants and Barriers to Market Entry
Table 46. ADC Drug Substance Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global ADC Drug Substance Sales Quantity by Region (2019-2024) & (Tons)
Table 48. Global ADC Drug Substance Sales Quantity by Region (2025-2030) & (Tons)
Table 49. Global ADC Drug Substance Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global ADC Drug Substance Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global ADC Drug Substance Average Price by Region (2019-2024) & (US$/Ton)
Table 52. Global ADC Drug Substance Average Price by Region (2025-2030) & (US$/Ton)
Table 53. Global ADC Drug Substance Sales Quantity by Type (2019-2024) & (Tons)
Table 54. Global ADC Drug Substance Sales Quantity by Type (2025-2030) & (Tons)
Table 55. Global ADC Drug Substance Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global ADC Drug Substance Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global ADC Drug Substance Average Price by Type (2019-2024) & (US$/Ton)
Table 58. Global ADC Drug Substance Average Price by Type (2025-2030) & (US$/Ton)
Table 59. Global ADC Drug Substance Sales Quantity by Application (2019-2024) & (Tons)
Table 60. Global ADC Drug Substance Sales Quantity by Application (2025-2030) & (Tons)
Table 61. Global ADC Drug Substance Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global ADC Drug Substance Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global ADC Drug Substance Average Price by Application (2019-2024) & (US$/Ton)
Table 64. Global ADC Drug Substance Average Price by Application (2025-2030) & (US$/Ton)
Table 65. North America ADC Drug Substance Sales Quantity by Type (2019-2024) & (Tons)
Table 66. North America ADC Drug Substance Sales Quantity by Type (2025-2030) & (Tons)
Table 67. North America ADC Drug Substance Sales Quantity by Application (2019-2024) & (Tons)
Table 68. North America ADC Drug Substance Sales Quantity by Application (2025-2030) & (Tons)
Table 69. North America ADC Drug Substance Sales Quantity by Country (2019-2024) & (Tons)
Table 70. North America ADC Drug Substance Sales Quantity by Country (2025-2030) & (Tons)
Table 71. North America ADC Drug Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America ADC Drug Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe ADC Drug Substance Sales Quantity by Type (2019-2024) & (Tons)
Table 74. Europe ADC Drug Substance Sales Quantity by Type (2025-2030) & (Tons)
Table 75. Europe ADC Drug Substance Sales Quantity by Application (2019-2024) & (Tons)
Table 76. Europe ADC Drug Substance Sales Quantity by Application (2025-2030) & (Tons)
Table 77. Europe ADC Drug Substance Sales Quantity by Country (2019-2024) & (Tons)
Table 78. Europe ADC Drug Substance Sales Quantity by Country (2025-2030) & (Tons)
Table 79. Europe ADC Drug Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe ADC Drug Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific ADC Drug Substance Sales Quantity by Type (2019-2024) & (Tons)
Table 82. Asia-Pacific ADC Drug Substance Sales Quantity by Type (2025-2030) & (Tons)
Table 83. Asia-Pacific ADC Drug Substance Sales Quantity by Application (2019-2024) & (Tons)
Table 84. Asia-Pacific ADC Drug Substance Sales Quantity by Application (2025-2030) & (Tons)
Table 85. Asia-Pacific ADC Drug Substance Sales Quantity by Region (2019-2024) & (Tons)
Table 86. Asia-Pacific ADC Drug Substance Sales Quantity by Region (2025-2030) & (Tons)
Table 87. Asia-Pacific ADC Drug Substance Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific ADC Drug Substance Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America ADC Drug Substance Sales Quantity by Type (2019-2024) & (Tons)
Table 90. South America ADC Drug Substance Sales Quantity by Type (2025-2030) & (Tons)
Table 91. South America ADC Drug Substance Sales Quantity by Application (2019-2024) & (Tons)
Table 92. South America ADC Drug Substance Sales Quantity by Application (2025-2030) & (Tons)
Table 93. South America ADC Drug Substance Sales Quantity by Country (2019-2024) & (Tons)
Table 94. South America ADC Drug Substance Sales Quantity by Country (2025-2030) & (Tons)
Table 95. South America ADC Drug Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America ADC Drug Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa ADC Drug Substance Sales Quantity by Type (2019-2024) & (Tons)
Table 98. Middle East & Africa ADC Drug Substance Sales Quantity by Type (2025-2030) & (Tons)
Table 99. Middle East & Africa ADC Drug Substance Sales Quantity by Application (2019-2024) & (Tons)
Table 100. Middle East & Africa ADC Drug Substance Sales Quantity by Application (2025-2030) & (Tons)
Table 101. Middle East & Africa ADC Drug Substance Sales Quantity by Region (2019-2024) & (Tons)
Table 102. Middle East & Africa ADC Drug Substance Sales Quantity by Region (2025-2030) & (Tons)
Table 103. Middle East & Africa ADC Drug Substance Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa ADC Drug Substance Consumption Value by Region (2025-2030) & (USD Million)
Table 105. ADC Drug Substance Raw Material
Table 106. Key Manufacturers of ADC Drug Substance Raw Materials
Table 107. ADC Drug Substance Typical Distributors
Table 108. ADC Drug Substance Typical Customers

LIST OF FIGURES

Figure 1. ADC Drug Substance Picture
Figure 2. Global ADC Drug Substance Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global ADC Drug Substance Consumption Value Market Share by Type in 2023
Figure 4. ADC Drug Substance Targeting Nectin-4 Examples
Figure 5. ADC Drug Substance Targeting Trop-2 Examples
Figure 6. Global ADC Drug Substance Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global ADC Drug Substance Consumption Value Market Share by Application in 2023
Figure 8. Drug R&D Examples
Figure 9. Medical Research Examples
Figure 10. Others Examples
Figure 11. Global ADC Drug Substance Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global ADC Drug Substance Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global ADC Drug Substance Sales Quantity (2019-2030) & (Tons)
Figure 14. Global ADC Drug Substance Average Price (2019-2030) & (US$/Ton)
Figure 15. Global ADC Drug Substance Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global ADC Drug Substance Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of ADC Drug Substance by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 ADC Drug Substance Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 ADC Drug Substance Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global ADC Drug Substance Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global ADC Drug Substance Consumption Value Market Share by Region (2019-2030)
Figure 22. North America ADC Drug Substance Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe ADC Drug Substance Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific ADC Drug Substance Consumption Value (2019-2030) & (USD Million)
Figure 25. South America ADC Drug Substance Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa ADC Drug Substance Consumption Value (2019-2030) & (USD Million)
Figure 27. Global ADC Drug Substance Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global ADC Drug Substance Consumption Value Market Share by Type (2019-2030)
Figure 29. Global ADC Drug Substance Average Price by Type (2019-2030) & (US$/Ton)
Figure 30. Global ADC Drug Substance Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global ADC Drug Substance Consumption Value Market Share by Application (2019-2030)
Figure 32. Global ADC Drug Substance Average Price by Application (2019-2030) & (US$/Ton)
Figure 33. North America ADC Drug Substance Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America ADC Drug Substance Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America ADC Drug Substance Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America ADC Drug Substance Consumption Value Market Share by Country (2019-2030)
Figure 37. United States ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe ADC Drug Substance Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe ADC Drug Substance Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe ADC Drug Substance Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe ADC Drug Substance Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific ADC Drug Substance Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific ADC Drug Substance Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific ADC Drug Substance Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific ADC Drug Substance Consumption Value Market Share by Region (2019-2030)
Figure 53. China ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America ADC Drug Substance Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America ADC Drug Substance Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America ADC Drug Substance Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America ADC Drug Substance Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa ADC Drug Substance Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa ADC Drug Substance Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa ADC Drug Substance Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa ADC Drug Substance Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa ADC Drug Substance Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. ADC Drug Substance Market Drivers
Figure 74. ADC Drug Substance Market Restraints
Figure 75. ADC Drug Substance Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of ADC Drug Substance in 2023
Figure 78. Manufacturing Process Analysis of ADC Drug Substance
Figure 79. ADC Drug Substance Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications